IQVIA

IQVIA is a global provider of data, technology, and services for the life sciences industry. The company combines real-world health data, advanced analytics, artificial intelligence, and domain expertise to support organizations across the full spectrum of drug development, commercialization, and regulatory compliance. IQVIA operates across the Americas, Europe, Asia and Oceania, and the Middle East and Africa, serving a broad range of clients including pharmaceutical manufacturers, emerging biopharma companies, generics producers, MedTech firms, consumer health organizations, payers, providers, government bodies, and patient associations.

IQVIA organizes its offerings into four primary solution areas — Research and Development, Real World Evidence, Commercialization, and Safety and Regulatory Compliance — each supported by proprietary technology platforms and AI capabilities.

Research and Development Solutions

• Early Phase Clinical Trials: Supports proof-of-concept studies and early drug development through clinical strategies designed to accelerate decision making.
• Phase IIb/III Trials: Uses AI and technology to help sponsors navigate regulatory complexity, optimize patient enrollment, and drive patient engagement in later-stage trials.
• Patient and Site Centric Solutions: Provides tools and services aimed at improving patient recruitment, engagement, and overall study execution at the site level.
• Functional Services: Delivers agile, data-driven trial solutions that connect people, processes, and technology to support faster R&D delivery.
• Global Laboratories: Offers specialty and central laboratory services with expertise in biomarkers and antibody drug discovery.
• R&D Consulting: Helps organizations optimize R&D strategy, reduce risk, and maintain compliance using data, analytics, and AI-powered technology.

Real World Evidence Solutions

• Real World and Health Data Sets: Provides access to global real-world data to generate insights across the product lifecycle.
• Medical Affairs: Offers end-to-end solutions for planning, generating, and disseminating medical evidence.
• Health Communications: Supports stakeholder engagement through targeted health communications.
• Health Data Apps and AI: Streamlines research processes through access to what IQVIA describes as the largest agnostic health data catalog.
• Health Data Transformation: Converts disparate health information into structured, insight-rich data at scale.
• Study Design: Assists in identifying appropriate study designs using data, technology, AI, and analytics.
• Evidence Networks: Connects data, technology, and analytics across global networks to broaden study options and enable collaboration.
• Health Economics and Value: Generates evidence to support market access, regulatory submissions, and payer approval processes.
• Regulatory and Safety (RWE): Applies real-world evidence study approaches to demonstrate product safety and effectiveness for regulatory purposes.
• Natural Language Processing: Extracts insights from unstructured text at scale using IQVIA's NLP platform.

Commercialization Solutions

• Data and Information Management: Supports business strategy and commercial decision making through data quality and management services.
• Commercial Analytics: Provides analytics to improve commercial effectiveness and support fact-based decision making.
• HCP Engagement: Enables targeted engagement with healthcare professionals to strengthen brand presence.
• Patient Engagement and Support: Delivers patient support programs and tools to assist patients throughout their treatment journey.
• Brand and Portfolio Strategy: Helps organizations shape commercial strategy and manage brand impact across the product lifecycle.
• Launch Strategy and Management: Supports product launches with planning and execution services aimed at maximizing market performance.
• Established Brands Optimization: Provides approaches to defend market share and maximize value for products already on the market.

Therapeutic and Specialty Areas

• IQVIA operates Therapeutic and Specialty Centers of Excellence that provide scientific expertise, therapeutic insights, and clinical trial experience across a wide range of disease areas.
• Covered therapeutic areas include Allergy and Respiratory, Biosimilars, Cardiovascular, Cell and Gene Therapy, Central Nervous System, Dermatology, Early Phase Clinical Development, Endocrinology, GI and Hepatology, Infectious Diseases and Vaccines, Nephrology, Obesity, Oncology and Hematology, Ophthalmology, Pediatrics, Rare Diseases, Reproductive Health, and Rheumatology.

Technology and AI

• IQVIA offers a dedicated AI platform referred to as IQVIA AI, which is applied across its R&D, real-world evidence, and commercial solution areas.
• The company describes its AI capabilities as healthcare-grade and integrates them with its proprietary data assets and domain expertise.
• Technology is embedded throughout the platform to support functions including clinical trial optimization, data transformation, NLP, and commercial analytics.

Safety and Regulatory Compliance

• IQVIA provides services and solutions covering the complete compliance lifecycle, including safety, regulatory affairs, and quality management.
• These offerings are described as service-driven and technology-enabled, with an integrated approach to compliance across the product lifecycle.

IQVIA operates globally with a presence across more than 40 countries and serves clients spanning pharmaceutical manufacturers, emerging biopharma, generics, MedTech, consumer health, financial institutions, government agencies, and healthcare providers, positioning itself as a broad-based partner across the life sciences and healthcare sectors.